SCHEMBL7009616

SCHEMBL7009616

CCOC(=O)c1ccc(C=CC(=O)NCc2cccn2-c2ccc(Cl)c(C(O[SiH](c3ccccc3)c3ccccc3)C(C)(C)C)c2Cl)cn1

nearest known ligand 0.44

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
BDKRB2 P30411 20/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7009652 0.91 BDKRB2 (0.47) BDKRB2
SCHEMBL7654580 0.86 BDKRB2 (0.50) BDKRB2
SCHEMBL7010306 0.84 BDKRB2 (0.55) BDKRB2
SCHEMBL7013009 0.80 BDKRB2 (0.52) BDKRB2
SCHEMBL7013000 0.80 BDKRB2 (0.52) BDKRB2
SCHEMBL7009610 0.80 BDKRB2 (0.50) BDKRB2
SCHEMBL7009606 0.80 BDKRB2 (0.50) BDKRB2
SCHEMBL8719709 0.80 BDKRB2 (0.48) BDKRB2
SCHEMBL7005682 0.78 KDM4E (0.33) BDKRB2
SCHEMBL8719706 0.74 BDKRB2 (0.46) BDKRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0861243-B1 HETEROCYCLIC COMPOUNDS AS BRADYKININ ANTAGONISTS FUJISAWA PHARMACEUTICAL CO (JP) 2003-11-12 EP disclosed
US-6344462-B1 Heterocyclic compounds as bradykinin antagonists FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-02-05 US disclosed
US-6100284-A ANTIALLERGENS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-08-08 US disclosed
US-6008229-A TREATING ALLERGY, INFLAMMATION, AUTOIMMUNE DISEASE, SHOCK, PAIN FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed
EP-0861243-A1 HETEROCYCLIC COMPOUNDS AS BRADYKININ ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-09-02 EP disclosed
WO-1997011069-A1 HETEROCYCLIC COMPOUNDS AS BRADYKININ ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-03-27 WO disclosed